With previously untreated Stage 3 or 4 Hodgkin lymphoma, first steps matter
Use the information below to familiarize yourself with important treatment considerations that can help you feel confident about the discussion and your treatment choice.
Treatment considerations for classical Hodgkin lymphoma
Learn more about what to consider when deciding on treatment, and see why ADCETRIS may be the right option for you.
*Brandon was compensated by Pfizer for participating in this campaign.
Here are some things to consider:
- How treatments work to kill cancer cells
- How well they may stop or slow the progress of your cancer
- How well they may improve overall survival
- How well results may be maintained long-term
- How side effects compare among treatments, and how they may be managed
- Dosing and how treatments are given
- The type of patient support available during treatment
Our Treatment Decision Guide can help
This downloadable guide helps answer these and other questions many new Hodgkin lymphoma patients have.
Use the guide to review the effectiveness of ADCETRIS, which aims to target a protein called CD30, plus AVD for previously untreated advanced stage Hodgkin lymphoma as compared to traditional ABVD chemotherapy.
Your first treatment choice matters
DID YOU KNOW:
Up to 30% of people with previously untreated Stage 3 or 4 Hodgkin lymphoma relapsed or didn’t respond after treatment with ABVD (traditional chemotherapy)?
Reported in 2 medical journals: Lancet and New England Journal of Medicine.
Your treatment, your choice
Your voice matters when it comes to making a first-time treatment decision for Stage 3 or 4 classical Hodgkin lymphoma
If your doctor doesn’t mention ADCETRIS as an option, it’s OK to ask about it. Don’t hesitate to speak up and ask questions. Familiarize yourself with all available treatments and seek a second opinion if that will help you feel confident about your treatment choice. While your doctor is the expert regarding your diagnosis, you and your care team are equal partners in the treatment decision. Your perspective and concerns play an essential role in selecting a treatment that works for you.
- Don’t hesitate to speak up and ask questions
- Familiarize yourself with all available treatments
- It’s OK to propose an option your doctor may not mention
- Seek a second opinion if that will help you feel confident about your choice
If you’re considering a first-time treatment for Stage 3 or 4 Hodgkin lymphoma, ADCETRIS plus AVD may be an option for you
In a large clinical study, ADCETRIS plus AVD was compared to traditional ABVD chemotherapy.
Brandon’s treatment journey
Knowing he just didn’t feel right, Brandon researched his symptoms and reached out to his doctor. Not satisfied with his initial consultation, he got a second opinion with another oncologist who listened to his concerns. After a few confirming tests, Brandon was diagnosed with Stage 4 classical Hodgkin lymphoma.
Collaborative treatment decision process
ADCETRIS will not work for everyone.
Relapsed classical Hodgkin lymphoma
For some people, cancer may relapse after initial treatment (stem cell transplant).
For others, certain treatments may not work to control tumor growth or treat cancer. However, they may still benefit from treatment with ADCETRIS if they failed at least 2 chemotherapy treatments and stem cell transplant is not an option.
See how ADCETRIS worked in people with relapsed classical Hodgkin lymphoma.
Consolidation after stem cell transplant
Sometimes people receive a stem cell transplant if their disease is not well controlled after initial treatment.
ADCETRIS may be given to reduce the risk of relapse or worsening disease. This is called consolidation treatment.
See how ADCETRIS worked in people given as consolidation treatment.
Glossary
ABVD: A combination of 4 chemotherapies—Adriamycin, bleomycin, vinblastine, and dacarbazine.
AVD: A combination of 3 chemotherapies—Adriamycin, vinblastine, and dacarbazine.
Consolidation treatment: Treatment that aims to kill any cancer cells that may be left in the body after initial treatment.
Relapse: When cancer has returned after a period of remission.
Remission: When signs and symptoms of cancer are reduced or undetectable.